DyoDelta EUROPEAN LIFE SCIENCE INNOVATION AWARDS

The European Life Science CEO Forum hosted the DyoDelta European Life Science Innovation Awards. The awards recognised the major investment and partnering deals in the industry and the awards dinner attracted more than 100 guests.

A note from the awards chairman:

“I am delighted with the success of the Sachs European Life Science CEO Forum in Zurich. The pharma/biotech sector awards we presented were in recognition of exceptional performance for hard-working organisations in Europe that succeeded in the categories of the "Pharma Partner of Choice of the Year", "Partnering Deal of the Year", "Investor of the Year" and "Financing of the Year".

I would like to extend a special thanks to our panel of distinguished judges for their support and congratulate the winners for the 4 categories respectively: GlaxoSmithKline, MorphoSys AG, Abingworth Management Limited & Global Life Science Ventures and EUSA Pharma. We look forward to repeating and expanding the awards for next year.”
Dimitri Dimitriou, Managing Partner of DyoDelta Biosciences More…

The winners were:

• European Pharma Partner of the Year
   Collected by Jose Maria Romero, Vice President Transactions,
   Late-Stage Projects & Worldwide Business Development, GlaxoSmithKline

• European Pharma Deal of the Year
   Collected by David Lemus, CFO, Morphosys AG

• European Life Science Investor of the Year (Joint winners)
   Collected by:
   Genghis Lloyd-Harris, Partner, Abingworth Management Limited
   &
   Hans A. Küpper, Partner, The Global Life Science Ventures GmbH

• European Financing of the Year
   Collected by Bryan Morton, CEO, EUSA Pharma

Our panel of expert judges from the pharma industry and the financial world that vote for the awards include:

Awards Judges Include:

• Dr Regina Hodits, Partner, Atlas Venture
• Harry Loveys, Principal, Capital Royalty LLC
• Dimitri Dimitriou, Partner, DyoDelta Biosciences
• Jose Maria Romero, Director Worldwide Business Development, GlaxoSmithKline
• Dr Margaret Beer, Director, Scientific Liaison, Licensing and External Research, Europe, Merck, Sharp & Dohme
• Dr Peter Johann, General Partner, NGN Capital
• Dr Alex Chanas, Senior Director, Worldwide Licensing and Business Development, Pfizer Inc.
• Sandrine Cailleteau, CBO, Plethora Solutions
• Laurent Feniou, Managing Director Healthcare, Rothschild
• Deborah Harland, Partner, SR One

Pharma deals have become more competitive, creative and complicated, while financing developments have shifted towards later-stage assets and lower risk, albeit with higher valuations. The industry and financial market trends recently present many challenges to companies and investors and we believe the awards will reflect this.

The awards are being organised by DyoDelta Biosciences (www.dyodelta.com), a specialist advisory practice in deal making in the pharma and biotech sector.